Marshall Wace, LLP
- SEC CIK
- 0001318757
- Latest filing
- Aug 13, 2026
CGON holding history
CG Oncology, Inc. in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CGON overviewAll 13F holders of CGONFull Q2 2026 holdings
- Shares (Q2 2026)
- 4,185
- Value
- $297.3K
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 4,185 | $297.3K | <0.1% | +4,185 | New | Holders |
| Q1 2026 | 0 | $0 | 0.0% | −261,110−100.0% | Sold out | Holders |
| Q4 2025 | 261,110 | $10.8M | <0.1% | +204,733+363.1% | Added | Holders |
| Q3 2025 | 56,377 | $2.27M | <0.1% | +56,377 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −2,418,456−100.0% | Sold out | Holders |
| Q1 2025 | 2,418,456 | $59.2M | 0.1% | +960,384+65.9% | Added | Holders |
| Q4 2024 | 1,458,072 | $41.8M | 0.1% | +1,450,372+18,836.0% | Added | Holders |
| Q3 2024 | 7,700 | $290.5K | <0.1% | −68,282−89.9% | Reduced | Holders |
| Q2 2024 | 75,982 | $2.40M | <0.1% | +75,982 | New | Holders |